Laura Iris Ferro
Laura is a manager and entrepreneur in the healthcare sector with strong academic background both in medical science and in business (MBA at Bocconi University, Milan).
In 2015 Laura was named among the 10 most innovative women managers in Italy by Wired and in 2006 she has been highlighted among the 10 ‘Women to watch’ by the Wall Street Journal Europe. After a period as psychiatrist in public structures (1978-1990), Laura joined the family pharmaceutical Company Crinos (then Sirton) holding a series of managerial offices. Leveraging on the experience of the family Company, she founded the biotech Gentium which then she listed in the USA at Nasdaq and sold to Jazz Pharmaceuticals (2014). She is from 2016 a member of the Board of Directors of the listed biotech company MolMed Spa. Laura is also Chairman of Bio4Dreams, the first incubator in the field of life sciences in Italy, and Vice-Chairman of IAG, the largest business angels network in the Country. Laura sits on the Board of Directors of start-ups operating in the field of neuromodulation such as Newronika and Wise and has been a Member of the Shareholdership Commission of IIT (Istituto Italiano di Tecnologia). She is a Board Member of Credem Private Equity Sgr. She was President of Pio Albergo Trivulzio (2011-2014), one of the main geriatric care facilities in Italy and Europe. She was also an Independent Director of Sorin Group (2012-2014), a multinational leader in the field of medical devices for the treatment of cardiovascular diseases which then merged with USA Company Cyberonics creating LivaNova.